Prescription profile and safety of oral capecitabine in metastatic colorectal cancer patients
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: FERNáNDEZ BARRANTES, Cristina (Caja Costarricense de Seguro Social/ Hospital San Juan de Dios, Drug Information Center, San José, Costa Rica)
- Co-author(s): Angelina Zumbado Arroyo:Pharmacy Service,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica|Cristina Fernández Barrantes:Drug Information Center,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica
Capecitabine is an oral fluoropyrimidine effective in the treatment of metastatic colorectal cancer, has a toxicity profile well established. The most common adverse reactions reported are hand-foot syndrome, diarrhea, stomatitis, nausea and vomiting. Capecitabine is generally considered well tolerated.
Observacional retrospective study, based on a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.